Publication:
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: Are there specific patient characteristics or biomarkers to indicate response to treatment?

Placeholder

Organizational Units

Program

Authors

Kocaturk, E.
Baskan, E. B.
Engin, B.
Ozdemir, M.
KÜÇÜK, ÖZLEM SU
Can, P.
Ornek, S.
Hasal, E.
Atakan, N.

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

0

Views

0

Downloads


Sustainable Development Goals